Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lesley Kay

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Clinical Medicine (London, England)|May 7, 2020
Identifying rheumatic disease patients at high risk and requiring shielding during the COVID-19 pandemicElizabeth Price, Elizabeth MacPhie, Lesley Kay, et al.
Lancet (London, England)|June 26, 2012
Defending the UK's National Health ServiceNicholas S Hopkinson, David J Nicholl, Kevin O'Kane, et al.
Health Technology Assessment (Winchester, England)|February 6, 2016
Tumour necrosis factor-α inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis: a systematic review and economic evaluationMark Corbett, Marta Soares, Gurleen Jhuti, et al.
BMC Musculoskeletal Disorders|November 13, 2015
The British Society for Rheumatology Biologics Registers in Ankylosing Spondylitis (BSRBR-AS) study: Protocol for a prospective cohort study of the long-term safety and quality of life outcomes of biologic treatmentGary J Macfarlane, Maxwell S Barnish, Elizabeth A Jones, et al.
Rheumatology (Oxford, England)|August 16, 2014
Factors influencing work disability in psoriatic arthritis: first results from a large UK multicentre studyWilliam Tillett, Gavin Shaddick, Ayman Askari, et al.
Rheumatology Advances in Practice|July 5, 2021
Feasibility, acceptability and change in health following a telephone-based cognitive behaviour therapy intervention for patients with axial spondyloarthritisRebecca Pedley, Linda E Dean, Ernest Choy, et al.
Rheumatology (Oxford, England)|November 14, 2018
Giant cell arteritis: new concepts, treatments and the unmet need that remainsFiona Coath, Kate Gillbert, Bridget Griffiths, et al.
Rheumatology (Oxford, England)|December 14, 2018
Giant cell arteritis: new concepts, treatments and the unmet need that remainsFiona Coath, Kate Gillbert, Bridget Griffiths, et al.
Rheumatology (Oxford, England)|December 26, 2016
Effect of anti-TNF and conventional synthetic disease-modifying anti-rheumatic drug treatment on work disability and clinical outcome in a multicentre observational cohort study of psoriatic arthritisWilliam Tillett, Gavin Shaddick, Amelia Jobling, et al.
Arthritis Care & Research|January 29, 2014
Development and testing of new candidate psoriatic arthritis screening questionnaires combining optimal questions from existing toolsLaura C Coates, Jessica Walsh, Muhammad Haroon, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Clinical Medicine (London, England)|May 7, 2020
Identifying rheumatic disease patients at high risk and requiring shielding during the COVID-19 pandemicElizabeth Price, Elizabeth MacPhie, Lesley Kay, et al.
Lancet (London, England)|June 26, 2012
Defending the UK's National Health ServiceNicholas S Hopkinson, David J Nicholl, Kevin O'Kane, et al.
Health Technology Assessment (Winchester, England)|February 6, 2016
Tumour necrosis factor-α inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis: a systematic review and economic evaluationMark Corbett, Marta Soares, Gurleen Jhuti, et al.
BMC Musculoskeletal Disorders|November 13, 2015
The British Society for Rheumatology Biologics Registers in Ankylosing Spondylitis (BSRBR-AS) study: Protocol for a prospective cohort study of the long-term safety and quality of life outcomes of biologic treatmentGary J Macfarlane, Maxwell S Barnish, Elizabeth A Jones, et al.
Rheumatology (Oxford, England)|August 16, 2014
Factors influencing work disability in psoriatic arthritis: first results from a large UK multicentre studyWilliam Tillett, Gavin Shaddick, Ayman Askari, et al.
Rheumatology Advances in Practice|July 5, 2021
Feasibility, acceptability and change in health following a telephone-based cognitive behaviour therapy intervention for patients with axial spondyloarthritisRebecca Pedley, Linda E Dean, Ernest Choy, et al.
Rheumatology (Oxford, England)|November 14, 2018
Giant cell arteritis: new concepts, treatments and the unmet need that remainsFiona Coath, Kate Gillbert, Bridget Griffiths, et al.
Rheumatology (Oxford, England)|December 14, 2018
Giant cell arteritis: new concepts, treatments and the unmet need that remainsFiona Coath, Kate Gillbert, Bridget Griffiths, et al.
Rheumatology (Oxford, England)|December 26, 2016
Effect of anti-TNF and conventional synthetic disease-modifying anti-rheumatic drug treatment on work disability and clinical outcome in a multicentre observational cohort study of psoriatic arthritisWilliam Tillett, Gavin Shaddick, Amelia Jobling, et al.
Arthritis Care & Research|January 29, 2014
Development and testing of new candidate psoriatic arthritis screening questionnaires combining optimal questions from existing toolsLaura C Coates, Jessica Walsh, Muhammad Haroon, et al.
Pageof 4